Clinical Metabolomics
Clinical metabolomics involves the application of clinical laboratory protocols, standards, and oversight of a global biochemical profiling technology whose results are interpreted relative to a reference adherent. The inevitable role of lipids in cell, tissue and organ physiology is explained by a large number of genetic studies and by many human diseases that involve the blockage of lipid metabolic enzymes and pathways. Examples of such diseases include diabetes, cancer as well as infectious diseases and neurodegenerative diseases. Within metabolomics, lipidomics has its own identity. Analytical approaches such as LC and MS for system-level analysis of lipids and their interacting partners now make this field a promising area of biomedical research, with a variety of applications in drug and biomarker development.
Related Conference of Clinical Metabolomics
Clinical Metabolomics Conference Speakers
Recommended Sessions
Related Journals
Are you interested in
- Advanced Biofuels and Sustainable Fuel Technologies - Biodiesel 2027 (France)
- Algae-Based Biofuels and Marine Bioenergy - Biodiesel 2027 (France)
- Biogas, Biomethane and Anaerobic Digestion - Biodiesel 2027 (France)
- Biohydrogen and Hydrogen Production from Biomass - Biodiesel 2027 (France)
- Biomass Conversion and Bioenergy Technologies - Biodiesel 2027 (France)
- Biorefineries and Integrated Biomass Processing - Biodiesel 2027 (France)
- Lignocellulosic Biomass and Cellulosic Biofuels - Biodiesel 2027 (France)
- Pyrolysis, Gasification and Hydrothermal Conversion - Biodiesel 2027 (France)
- Sustainable Aviation Fuels and Renewable Transportation - Biodiesel 2027 (France)
- Sustainable Biomass Feedstocks and Supply Chains - Biodiesel 2027 (France)
